Acknowledgement
This study was supported by a grant from the Korea Healthcare technology R&D Projects, Ministry for Health, Welfare & Family Affairs (HI16C1111), by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2016M3C7A1914002), by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2017R1A2B2006526), by Creative-Pioneering Researchers Program through Seoul National University (SNU), and by Project Code (IBS-R006-D1).
References
- Eidel O, Burth S, Neumann JO, Kieslich PJ, Sahm F, Jungk C, et al. Tumor infiltration in enhancing and non-enhancing parts of glioblastoma: a correlation with histopathology. PLoS One 2017;12:e0169292
- Barajas RF Jr, Phillips JJ, Parvataneni R, Molinaro A, Essock-Burns E, Bourne G, et al. Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging. Neuro Oncol 2012;14:942-954 https://doi.org/10.1093/neuonc/nos128
- Oh J, Henry RG, Pirzkall A, Lu Y, Li X, Catalaa I, et al. Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J Magn Reson Imaging 2004;19:546-554 https://doi.org/10.1002/jmri.20039
- Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-996 https://doi.org/10.1056/NEJMoa043330
- Albert FK, Forsting M, Sartor K, Adams HP, Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 1994;34:45-60; discussion 60-61 https://doi.org/10.1227/00006123-199401000-00008
- Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 2010;28:1963-1972 https://doi.org/10.1200/JCO.2009.26.3541
- Norden AD, Drappatz J, Muzikansky A, David K, Gerard M, McNamara MB, et al. An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma. J Neurooncol 2009;92:149-155 https://doi.org/10.1007/s11060-008-9745-8
- Hardee ME, Zagzag D. Mechanisms of glioma-associated neovascularization. Am J Pathol 2012;181:1126-1141 https://doi.org/10.1016/j.ajpath.2012.06.030
- Jain R. Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications. NMR Biomed 2013;26:1042-1049 https://doi.org/10.1002/nbm.2994
- Jia Z, Geng D, Xie T, Zhang J, Liu Y. Quantitative analysis of neovascular permeability in glioma by dynamic contrast-enhanced MR imaging. J Clin Neurosci 2012;19:820-823 https://doi.org/10.1016/j.jocn.2011.08.030
- Jung SC, Yeom JA, Kim JH, Ryoo I, Kim SC, Shin H, et al. Glioma: application of histogram analysis of pharmacokinetic parameters from T1-weighted dynamic contrast-enhanced MR imaging to tumor grading. AJNR Am J Neuroradiol 2014;35:1103-1110 https://doi.org/10.3174/ajnr.A3825
- Cao Y, Nagesh V, Hamstra D, Tsien CI, Ross BD, Chenevert TL, et al. The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas. Cancer Res 2006;66:8912-8917 https://doi.org/10.1158/0008-5472.CAN-05-4328
- Ulyte A, Katsaros VK, Liouta E, Stranjalis G, Boskos C, Papanikolaou N, et al. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients. Neuroradiology 2016;58:1197-1208 https://doi.org/10.1007/s00234-016-1741-7
- Kim R, Choi SH, Yun TJ, Lee ST, Park CK, Kim TM, et al. Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging. Eur Radiol 2017;27:1176-1185 https://doi.org/10.1007/s00330-016-4464-6
- Nam JG, Kang KM, Choi SH, Lim WH, Yoo RE, Kim JH, et al. Comparison between the prebolus T1 measurement and the fixed T1 value in dynamic contrast-enhanced MR imaging for the differentiation of true progression from pseudoprogression in glioblastoma treated with concurrent radiation therapy and temozolomide chemotherapy. AJNR Am J Neuroradiol 2017;38:2243-2250 https://doi.org/10.3174/ajnr.A5417
- Tietze A, Mouridsen K, Mikkelsen IK. The impact of reliable prebolus T1 measurements or a fixed T1 value in the assessment of glioma patients with dynamic contrast enhancing MRI. Neuroradiology 2015;57:561-572 https://doi.org/10.1007/s00234-015-1502-z
- Haacke EM, Filleti CL, Gattu R, Ciulla C, Al-Bashir A, Suryanarayanan K, et al. New algorithm for quantifying vascular changes in dynamic contrast-enhanced MRI independent of absolute T1 values. Magn Reson Med 2007;58:463-472 https://doi.org/10.1002/mrm.21358
- Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991;17:357-367 https://doi.org/10.1002/mrm.1910170208
- Sundar H, Shen D, Biros G, Xu C, Davatzikos C. Robust computation of mutual information using spatially adaptive meshes. Med Image Comput Comput Assist Interv 2007;10(Pt 1):950-958 https://doi.org/10.1007/978-3-540-75757-3_115
- Pluim JP, Maintz JB, Viergever MA. Mutual-information-based registration of medical images: a survey. IEEE Trans Med Imaging 2003;22:986-1004 https://doi.org/10.1109/TMI.2003.815867
- Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001;95:190-198 https://doi.org/10.3171/jns.2001.95.2.0190
- Hammoud MA, Sawaya R, Shi W, Thall PF, Leeds NE. Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neurooncol 1996;27:65-73 https://doi.org/10.1007/BF00146086
- Cha S, Johnson G, Wadghiri YZ, Jin O, Babb J, Zagzag D, et al. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med 2003;49:848-855 https://doi.org/10.1002/mrm.10446
- Choi YS, Kim DW, Lee SK, Chang JH, Kang SG, Kim EH, et al. The added prognostic value of preoperative dynamic contrast-enhanced MRI histogram analysis in patients with glioblastoma: analysis of overall and progression-free survival. AJNR Am J Neuroradiol 2015;36:2235-2241 https://doi.org/10.3174/ajnr.A4449
- Aref M, Chaudhari AR, Bailey KL, Aref S, Wiener EC. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates. Magn Reson Imaging 2008;26:1279-1293 https://doi.org/10.1016/j.mri.2008.02.015
- Bisdas S, Smrdel U, Bajrovic FF, Surlan-Popovic K. Assessment of progression-free-survival in glioblastomas by intratreatment dynamic contrast-enhanced MRI. Clin Neuroradiol 2016;26:39-45 https://doi.org/10.1007/s00062-014-0328-0
- Nguyen TB, Cron GO, Perdrizet K, Bezzina K, Torres CH, Chakraborty S, et al. Comparison of the diagnostic accuracy of DSC- and dynamic contrast-enhanced MRI in the preoperative grading of astrocytomas. AJNR Am J Neuroradiol 2015;36:2017-2022 https://doi.org/10.3174/ajnr.A4398
- Barajas RF Jr, Hodgson JG, Chang JS, Vandenberg SR, Yeh RF, Parsa AT, et al. Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging. Radiology 2010;254:564-576 https://doi.org/10.1148/radiol.09090663